Details for New Drug Application (NDA): 019698
✉ Email this page to a colleague
NDA 019698 describes TORADOL, which is a drug marketed by Roche Palo and is included in two NDAs. Additional details are available on the TORADOL profile page.
The generic ingredient in TORADOL is ketorolac tromethamine. There are eighteen drug master file entries for this compound. Sixty-nine suppliers are listed for this compound. Additional details are available on the ketorolac tromethamine profile page.
The generic ingredient in TORADOL is ketorolac tromethamine. There are eighteen drug master file entries for this compound. Sixty-nine suppliers are listed for this compound. Additional details are available on the ketorolac tromethamine profile page.
Summary for 019698
| Tradename: | TORADOL |
| Applicant: | Roche Palo |
| Ingredient: | ketorolac tromethamine |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 019698
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 15MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Nov 30, 1989 | TE: | RLD: | Yes | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 30MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Nov 30, 1989 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
